Industry news and our latest thoughts on the issues that matter most in Cell Therapy.

hPSC-ATMP manufacture - Where are we now?

Featured news and insights

  • hPSC-ATMP manufacture - Where are we now?

    Read our first white paper on Manufacturing in a series of white papers that we’ve produced post conducting our pilot study with Tillväxtverket.

    Author, HOYA co-founder Heather Main.

  • An hPSC-ATMP innovation catalyst in Sweden - pilot study

    Read the ATMP Sweden article summarising the hPSC-ATMP TVV pilot study and our company formation!

  • Gör Sverige ledande på framtidens läkemedel

    Regeringen står nu inför ett vägval: växla upp arbetet med framtidens läkemedel eller ge bort möjligheten att utveckla dessa läkemedel till andra länder som också ligger i framkant.

  • Synergy in cell therapy development through mutual respect

    The Novo Nordisk/Karolinska Institutet/St Erik/Vecura model, written and lived by Dr Heather Main, Co-founder at HOYA.

  • Regenerative Medicine: The Pipeline Momentum Builds

    Clinical milestones, regulatory developments, and patient impact steadily advance for the cell and gene sector.

    H1, 2022 report.